Sylvia C. Kurz, MD, PhD

Media Releases

Internationally Acclaimed Specialist Brings Expertise in Brain Tumors and Immunotherapy to Yale’s Chênevert Family Brain Tumor Center

An esteemed neuro-oncologist, Dr. Kurz is an Associate Professor of Neurology at the Chênevert Family Brain Tumor Center at Smilow Cancer Hospital at New Haven, Connecticut. She is an internationally acclaimed neuro-oncologist whose extensive education and experience in the field position her as a leader in the treatment and research of brain tumors.

She earned both her medical degree and PhD from Ludwig-Maximilians-University in Munich, Germany. She completed neurology residency at University Hospitals Case Medical Center and an esteemed fellowship in Neuro-Oncology Fellowship Program at the Massachusetts General Hospital/Dana-Farber Cancer Institute/Brigham and Women’s Hospital in Boston. After serving as an Assistant Professor and Interim Director of the Neuro-Oncology Program at Perlmutter Cancer Center in New York, she returned to Germany to work at the Institute for Neurology and Interdisciplinary Neuro-Oncology at the University Hospital Tübingen and Eberhard Karls University of Tübingen. 

At Yale, Dr. Kurz leverages her expertise to care for patients with brain tumors, particularly gliomas and meningiomas, and those who experience cancer- and cancer therapy-associated side effects of the nervous system. Her personalized and patient-centered approach ensures that each individual receives the best possible care tailored to their unique needs.

In addition to her clinical responsibilities, she is deeply involved in translational and clinical research, working as a principal investigator on numerous investigator-initiated, cooperative group and industry-sponsored clinical trials, including several focused on immunotherapy. She is dedicated to developing innovative treatment options for patients with progressive and therapy-resistant gliomas and intracranial meningiomas, a particularly challenging area in neuro-oncology.

Recommended Articles

• How to Deal with Lymphoma Treatment Fatigue

  Treatment fatigue is a very common problem among lymphoma patients. Whether the patient is doing pharmaceutical treatments, chemotherapy, or other treatments, they will likely lead to fatigue and a feeling of being burnt out.This article will go over what treatment fatigue is, symptoms that are...

• Inspirational Blood Cancer Survivors

  Different forms of blood cancer are responsible for claiming the third most lives out of all the types of cancer. Additionally, there are currently no known preventative treatments for blood cancers, and the disease also impacts children and young people more than any other form of cancer.When it...

• Bringing Chronic Lymphocytic Leukemia Patients and Their Doctors Together via Survey

  While patients may entirely admire and respect their doctors, sometimes they simply do not agree with the course of action they are proposing. While this may not be a big deal for a visit about a cold or something minimal, it can be life-altering for those with chronic conditions. That is why a...

• Treatment Update for Hodgkin Lymphoma

  Over time, research has uncovered ways of treating Hodgkin lymphoma (HL) to produce an 80% to 90% cure rate. For the remaining 10% to 20% who are either resistant to the primary treatment or have relapsed, their cancer can still be fatal.The standard care for those not yet cured has been a two-step...

• Schools Join the Fight Against Lymphoma and Blood Cancers

  Students at St. Paul Catholic School in Weirton, West Virginia have made their mark in the battle against cancer. By participating in a Student Series program hosted by the Leukemia and Lymphoma Society, students were able to raise $2,006.93 and donate the proceeds to discovering a cure for...

• 'Sophie the Brave' Fights Childhood T-Cell Lymphoma

  The story of 2-year-old Sophie Skiles and her arduous battle with T-cell lymphoma pulls at one’s heartstrings while also causing one to marvel at the faith of her Mom, Shelby.The public first learned of Sophie when a newscast about her was posted online October 20, 2017. (KLTB/abc) It soon made it...